Business
Pheton Holdings Ltd Announces Closing of Share Acquisition with iTonic Corporation
Beijing, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) (“Pheton” or the “Company”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the successful completion of its acquisition of 51% of the total outstanding shares of iTonic Corporation (the “Target”), a U.S.-based integrated home health AI company that combines AI, medical device automation, and easier access to cl
About this update from Target Corporation
[{"type":"image","alt":"Pheton Holdings Ltd.","displaySize":"","headline":null,"caption":"Pheton Holdings Ltd.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":134,"url":"https://media.zenfs.com/en/globenewswire.com/952011f91d3705f47c2246bb9174b7f9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/bOb_RAO50VEwA2PJ6chF7w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/952011f91d3705f47c2246bb9174b7f9","width":300,"height":134}},"lazy":false},{"type":"text","content":"Beijing, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) (“Pheton” or the “Company”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the successful completion of its acquisition of 51% of the total outstanding shares of iTonic Corporation (the “Target”), a U.S.-based integrated home health AI company that combines AI, medical device automation, and easier access to clinical expertise to support continuity of care in the home (the “Share Acquisition”). This strategic acquisition aligns with the Company's commitment to enhancing its portfolio in the healthcare technology landscape, enabling the firm to broaden its reach and to seek better patient outcomes through advanced solutions.","length":823,"tagName":"p"},{"type":"text","content":"This acquisition, which was announced in a Report on Form 6-K on August 29, 2025, involved a Stock Purchase Agreement (the “SPA”) with iTonic and certain shareholders (the “Selling Shareholders”). As part of the consideration for the Share Acquisition, Pheton agreed to issue to the Selling Shareholders 4,000,000 newly issued Class A ordinary shares which are subject to performance milestones, alongside warrants granting the Selling Shareholders the right to purchase up to 3,000,000 Class A ordinary shares of Pheton at an exercise price of $3.10 per share (the “Warrants”), which will become exercisable in separate tranches, with each tranche becoming eligible for exercise upon the Target’s achievement of the applicable quarterly or annual performance milestones set forth in the SPA. The closing of the Share Acquisition took place on November 25, 2025, upon which the Selling Shareholders transferred their equity interests to the Company, and the T...